Gail Cawkwell, MD, PhD

Senior Vice President, Medical Affairs

Intercept Pharmaceuticals

Dr. Gail Cawkwell joined Intercept on February 12, 2018 as Senior Vice President of Medical Affairs.   She and her team are responsible for providing trusted medical and scientific expertise to healthcare professionals, payers, patients, health systems, and others to assure their understanding and knowledge of Ocaliva and relevant liver diseases. 

Gail has more than 17 years of pharmaceutical development and medical affairs experience. Prior to joining Intercept, Gail was Chief Medical Officer at Purdue Pharma, and, prior to that, she was Vice President in the Medicines Development Group at Pfizer. She began her pharmaceutical career as Medical Director for Pfizer’s Celebrex and progressed to roles of increasing responsibility in Pfizer’s US and Global Medical Affairs functions.

Gail received a BS degree at Duke University, an MD degree from McGill University and completed a PhD at the University of Cincinnati in the Department of Environmental Health, Division of Biostatistics and Epidemiology. She completed a Residency in Pediatrics at Duke University Medical Center and a Fellowship in Pediatric Rheumatology at Cincinnati’s Children’s Hospital Medical Center.

Stay Connected with MAPS

Join MAPS on LinkedIn to further build your professional connections within Medical Affairs through our Company and Group Pages.

Follow us on Twitter and say abreast of MAPS activities and key issues for Medical Affairs professionals.